Fumarate reductase activity maintains an energized membrane in anaerobic Mycobacterium tuberculosis von Watanabe, Shinya, Zimmermann, Michael, Goodwin, Michael B, Sauer, Uwe, Barry, 3rd, Clifton E, Boshoff, Helena I

Volltext

SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc 1 inhibitors von Phummarin, Narisa, Boshoff, Helena I, Tsang, Patricia S, Dalton, James, Wiles, Siouxsie, Barry Rd, Clifton E, Copp, Brent R

Volltext

Predicting TB treatment outcomes using baseline risk and treatment response markers: developing the PredictTB early treatment completion criteria von Chen, Ray Y., Wang, Jing, Liang, Lili, Xie, Yingda L., Malherbe, Stephanus T., Winter, Jill, Via, Laura E., Yu, Xiang, Vincent, Joel, Armstrong, Derek, Walzl, Gerhard, Alland, David, Barry rd, Clifton E., Dodd, Lori E.

Volltext

SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc1 inhibitors von Phummarin, Narisa, Boshoff, Helena I, Tsang, Patricia S, Dalton, James, Wiles, Siouxsie, Barry 3rd, Clifton E, Copp, Brent R

Volltext

S02-4 In Vivo Imaging of Tuberculosis and its' Response to Chemotherapy von Clifton E. Barry

Volltext